FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to hematology, and can be applied for treatment of hereditary anemias, associated with failure of porphyrine synthesis. For this purpose per orally introduced is 5-aminolevulinic acid or its hexyl ether in doses, which insure compensation of insufficient biosynthesis of 5-aminolevulinic acid by organism.
EFFECT: method insures fast and effective increase of hemoglobin level in treatment of said pathology in experiment.
3 ex, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PREPARATION FOR TREATING AND PREVENTING ALIMENTARY ANAEMIA IN YOUNG PIGS | 2013 |
|
RU2540506C2 |
| PHARMACOLOGICAL COMPOSITION BASED ON WATER-SOLUBLE POLYMETAL COMPLEXES OF POLYGALACTURONIC ACID, STIMULATING HEMATOPOIESIS PROCESS | 2019 |
|
RU2704033C1 |
| METHOD FOR EXPERIMENTAL MODELING OF IRON DEFICIENCY ANEMIA IN LABORATORY ANIMALS | 2021 |
|
RU2782797C1 |
| TREATMENT-AND-PROPHYLACTIC CHELATE IRON CONTAINING DRUG FOR FARM ANIMALS | 2016 |
|
RU2623071C1 |
| METHOD TO PREVENT AND TREAT DEFICIENCY ANAEMIA AND TO PREVENT HYPOPLASTIC ANAEMIA IN PIGLETS | 2010 |
|
RU2429863C1 |
| TETRAKIS-(L-HISTIDINATO)-μ-PEROXYDICOBALT)III HEPTAHYDRATE HAVING ANTIANEMIC, RADIOPROTECTIVE AND ANTIARRHYTHMIC ACTIVITIES | 1999 |
|
RU2151773C1 |
| PREPARATION FOR TREATING AND PREVENTING IRON-DEFICIENT CONDITIONS IN ANIMALS | 2010 |
|
RU2455999C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING CENTRAL AND PERIPHERAL NERVOUS SYSTEM DISORDERS OF CARDIOVASCULAR, TRAUMATIC, TOXIC, HYPOXIC AND AUTOIMMUNE GENESIS | 2010 |
|
RU2445106C1 |
| BIOLOGICALLY ACTIVE COMPOSITION WITH ADAPTOGENIC ACTION | 2015 |
|
RU2620562C2 |
| PREPARATION TO PREVENT AND TREAT INFECTIOUS DISEASES AND CORRECT PATHOLOGICAL STATES | 1998 |
|
RU2177788C2 |
